[1] |
JENNETTE J C, FALK R J, BACON P A,et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides[J]. Arthritis Rheum,2013,65(1):1-11. DOI:10.1002/art.37715.
|
[2] |
SHI D, CHAN H, YANG X,et al. Risk factors associated with IgA vasculitis with nephritis (Henoch-Schönlein Purpura nephritis) progressing to unfavorable outcomes:a meta-analysis[J]. PLoS One,2019,14(10):e0223218. DOI:10.1371/journal.pone.0223218.
|
[3] |
LI Y Y, LI C R, WANG G B,et al. Investigation of the change in CD4+ T cell subset in children with Henoch-Schonlein Purpura[J]. Rheumatol Int,2012,32(12):3785-3792. DOI:10.1007/s00296-011-2266-3.
|
[4] |
OZEN S. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides[J]. Ann Rheum Dis,2005,65(7):936-941. DOI:10.1136/ard.2005.046300.
|
[5] |
中华医学会儿科学分会肾脏学组. 紫癜性肾炎诊治循证指南(2016)[J]. 中华儿科杂志,2017,55(9):647-651.
|
[6] |
杨思睿,刘德滢,王晶华,等. IgA血管炎的免疫机制和治疗现状及展望[J].中华实用儿科临床杂志,2016,31(9):641-645.DOI:10.3760/cma.j.issn.2095-428X.2016.09.001.
|
[7] |
孙莹莹,刘霞,黄岩杰. 辅助T淋巴细胞17及白细胞介素-17在过敏性紫癜及紫癜性肾炎发病中的作用[J]. 现代中西医结合杂志,2016,25(5):567-570. DOI:10.3969/j.issn.1008-8849.2016.05.040.
|
[8] |
DOLFF S, WITZKE O, WILDE B. Th17 cells in renal inflammation and autoimmunity[J]. Autoimmun Rev,2019,18(2):129-136. DOI:10.1016/j.autrev.2018.08.006.
|
[9] |
TURNER J E, PAUST H J, STEINMETZ O M,et al. The Th17 immune response in renal inflammation[J]. Kidney Int,2010,77(12):1070-1075. DOI:10.1038/ki.2010.102.
|
[10] |
SCHMIDT T, LUEBBE J, PAUST H J,et al. Mechanisms and functions of IL-17 signaling in renal autoimmune diseases[J]. Mol Immunol,2018,104:90-99. DOI:10.1016/j.molimm.2018.09.005.
|
[11] |
陈敏广,林瑞霞,杨青,等. 儿童过敏性紫癜肾炎血清中IFN-γ水平及临床意义[J]. 中国中西医结合肾病杂志,2005,6(11):659-660.
|
[12] |
RICE E K, NIKOLIC-PATERSON D J, HILL P A,et al. Interferon-gamma induces macrophage migration inhibitory factor synthesis and secretion by tubular epithelial cells[J]. Nephrology,2003,8(3):156-161. DOI:10.1046/j.1440-1797.2003.00152.x.
|
[13] |
LU H, BAI Y Y, WU L F,et al. Inhibition of macrophage migration inhibitory factor protects against inflammation and matrix deposition in kidney tissues after injury[J]. Mediat Inflamm,2016,2016:1-12. DOI:10.1155/2016/2174682.
|
[14] |
GÜLHAN B, ORHAN D, KALE G,et al. Studying cytokines of T helper cells in the kidney disease of IgA vasculitis (Henoch-Schönlein Purpura)[J]. Pediatr Nephrol,2015,30(8):1269-1277. DOI:10.1007/s00467-015-3051-4.
|
[15] |
KAPLANSKY G, BONGRAND P. Cytokines and chemokines[J]. Cell Mol Biol (Noisy-le-grand),2001,47(4):569-574.
|
[16] |
ZHANG H F, LIANG G B, ZHAO M G,et al. Regulatory T cells demonstrate significantly increased functions following stimulation with IL-2 in a Tim-3-dependent manner in intracranial aneurysms[J]. Int Immunopharmacol,2018,65:342-347. DOI:10.1016/j.intimp.2018.10.029.
|
[17] |
KAWASAKI Y, SUZUKI J, SAKAI N,et al. Evaluation of T helper-1/-2 balance on the basis of IgG subclasses and serum cytokines in children with glomerulonephritis[J]. Am J Kidney Dis,2004,44(1):42-49. DOI:10.1053/j.ajkd.2004.03.029.
|
[18] |
江华,丁甫月,顾龙君. 过敏性紫癜患儿血清IFN-α、IL-2、IL-4、TNF-α水平的变化[J]. 中国当代儿科杂志,2002,4(2):117-118.
|
[19] |
LI M M, LIU N, ZHAGN M,et al. Clinical significance of serum midkine in children with henoch-schonlein Purpura[J]. Zhongguo Shi Yan Xue Ye Xue Za Zhi,2017,25(1):181-185. DOI:10.7534/j.issn.1009-2137.2017.01.032.
|
[20] |
MALEK T R. The main function of IL-2 is to promote the development of T regulatory cells[J]. J Leukoc Biol,2003,74(6):961-965. DOI:10.1189/jlb.0603272.
|
[21] |
潘凯丽,白庆峰,黄莹,等. 过敏性紫癜患儿血清白细胞介素-4、-6、-8及肿瘤坏死因子-α表达的意义[J]. 实用儿科临床杂志,2007,22(21):1632-1633.
|
[22] |
翁小斌,鲍金芳. 过敏性紫癜患儿血清IL-6、IL-12、TFN-α水平变化及临床意义[J]. 浙江医学,2014,36(9):791-792.
|
[23] |
MAKITA Y, SUZUKI H, KANO T,et al. TLR9 activation induces aberrant IgA glycosylation via APRIL-and IL-6-mediated pathways in IgA nephropathy[J]. Kidney Int,2020,97(2):340-349. DOI:10.1016/j.kint.2019.08.022.
|
[24] |
金丽威.白介素10家族研究近况[J].国外医学(免疫学分册),2005,28(4):246-249.
|
[25] |
WU H T, WEN Y B, YUE C,et al. Serum TNF-α level is associated with disease severity in adult patients with immunoglobulin a vasculitis nephritis[J]. Dis Markers,2020,2020:1-7. DOI:10.1155/2020/5514145.
|